鳥類のコクシディオシスに関する洞察:薬学および予防戦略のための抗コクシディオ薬とハーブ植物への二重の焦点
Pooja Bharti1, Syed Tanveer1, Zahoor Ahmad Wani2
1Department of Zoology, University of Kashmir, Kashmir, J & K 190006 India.
まとめ
コクシディオシスは家禽の大量死を引き起こす. このレビューでは,薬剤,薬草薬剤,ワクチンなどの抗菌剤の介入を調査し,薬剤耐性エイメリア菌株に対する効果を比較しています.
科学分野:
- 獣医の寄生病学
- 鶏の健康管理
- プロトゾア病
背景:
- コクシディオシスは家禽産業にとって大きな経済的脅威であり,高い死亡率と罹病率を引き起こしています.
- 従来の抗菌薬に対する耐性は,代替の制御戦略の探索を必要とします.
- 薬剤のない家禽産物への需要は増加しており,より安全な介入への研究を推進しています.
研究 の 目的:
- 鳥類におけるコクシディオシスの制御のための様々な抗コクシディアの介入を包括的に検討し,分析する.
- 商業用医薬品,ハーブ混合物,プロバイオティクス,ナノ粒子,エッセンシャルオイル,ワクチンの有効性を評価する.
- これらの代替薬の有効性を従来の抗菌薬と比較する.
主な方法:
- コクシディオシスとその対策に関する科学出版物の文献レビュー
- 様々な介入の抗菌活動に関するデータの分析
- 出版された研究に基づいた有効性の比較評価
主要な成果:
- 抗菌薬は有効ですが 耐性問題も増えています
- 薬草,エッセンシャルオイル,ワクチンは 代替品として有望です
- 新興戦略にはペプチド,植物性,トランスジェニックワクチンが含まれる.
結論:
- 天然製品やワクチンを含む様々な抗菌薬は 従来の薬の有効な代替品です
- これらの代替案を最適化して 広く適用するには 更に研究開発が必要である.
- 持続可能な家禽の生産には 新種のワクチン技術と薬剤のないアプローチを重視することが不可欠です
関連する概念動画
Biological Methods for Microbial Control
199
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
199
Microorganisms in Medicine and Therapeutics
312
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
312
Combined Effects of Drugs: Synergism
4.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.7K
Fungal Phylum Microsporidia
111
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
111
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
201
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
201
Drugs for Treatment of Constipation-Predominant IBS
326
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
326


